Tumor-derived RHOA mutants interact with effectors in the GDP-bound state
RHOA mutations are found at diverse residues in various cancer types, implying mutation- and cell-specific mechanisms of tumorigenesis. Here, we focus on the underlying mechanisms of two gain-of-function RHOA mutations, A161P and A161V, identified in adult T-cell leukemia/lymphoma. We find that RHOA<sup>A161P</sup> and RHOA<sup>A161V</sup> are both fast-cycling mutants with increased guanine nucleotide dissociation/association rates compared with RHOA<sup>WT</sup> and show reduced GTP-hydrolysis activity. Crystal structures reveal an altered nucleotide association in RHOA<sup>A161P</sup> and an open nucleotide pocket in RHOA<sup>A161V</sup>. Both mutations perturb the dynamic properties of RHOA switch regions and shift the conformational landscape important for RHOA activity, as shown by <sup>31</sup>P NMR and molecular dynamics simulations. Interestingly, RHOA<sup>A161P</sup> and RHOA<sup>A161V</sup> can interact with effectors in the GDP-bound state. <sup>1</sup>H-<sup>15</sup>N HSQC NMR spectra support the existence of an active population in RHOA<sup>A161V</sup>-GDP. The distinct interaction mechanisms resulting from the mutations likely favor an RHOA<sup>WT</sup>-like "ON" conformation, endowing GDP-bound state effector binding activity.
Authors
- Yi Zheng (ORCID: https://orcid.org/0000-0001-7089-6074)
- Ruth Nussinov (ORCID: https://orcid.org/0000-0002-8115-6415)
- Simge Senyuz (ORCID: https://orcid.org/0000-0003-1945-2288)
- Theresa A. Ramelot (ORCID: https://orcid.org/0000-0002-0335-1573)
- Attila Gürsoy (ORCID: https://orcid.org/0000-0002-2297-2113)
- Özlem Keskin (ORCID: https://orcid.org/0000-0002-4202-4049)
- Hyunbum Jang (ORCID: https://orcid.org/0000-0001-9402-4051)
- Yuan Lin (ORCID: https://orcid.org/0000-0002-4375-9805)
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Koç University (TR)
- Rensselaer Polytechnic Institute (US)
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1038/s41467-024-51445-z
- Citations
- 7
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 1.64
Funders
- Eli Lilly and Company
- CancerFree KIDS
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Argonne National Laboratory